Refeyn
PrivateLast Round
Series B
Apr 11, 2022
Total Funding Raised
$99.93M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Refeyn operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series B round in April 2022.
Refeyn is a life sciences instrumentation company that develops, produces, and distributes mass photometry technology for the analysis of individual molecules in solution.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refeyn Comparables
Compare Refeyn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoTemper Technologies | 78% | |
| Unchained Labs | 76% | |
| Nicoya Lifesciences Inc. | 74% |
For institutional investors. Book with your work email.
Refeyn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 11, 2022 | ||||
| Series A | Nov 1, 2020 | ||||
| Seed | Mar 4, 2019 | ||||
| Seed | Jun 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Refeyn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foresight Group Holdings Limited | Series B |
| Horizons Ventures | Series A, Series B |
| Oxford Science Enterprises | Series A, Series B, Seed |
| Northpond Ventures | Series A, Series B |
| University of Oxford | Seed, Series A, Series B |
| Foresight Group LLP | Series A, Series B |
| Foresight Williams Technology | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2026
Received Committed Status by the Inclusive Employers Standard in 2024.
- Mar 18, 2026
Launched the MyMass instrument for sample quality assessment.
For institutional investors. Book with your work email.
Refeyn Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Refeyn's valuation, stock price, and market status.
Is Refeyn a public or private company?
Refeyn is a private company.
What is the current stock price of Refeyn?
Refeyn is a private company, so its shares have no public market price. Caplight tracks Refeyn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Refeyn worth (valuation)?
Valuation information for Refeyn is not publicly available.
Can I buy Refeyn stock?
Refeyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Refeyn's last funding round?
Refeyn's most recent funding round was Series B on April 11, 2022.
Who are the main investors in Refeyn?
Key investors in Refeyn include Oxford Science Enterprises, Northpond Ventures, Foresight Williams Technology.
Will Refeyn IPO soon?
No public IPO plans have been announced for Refeyn.
How can I track Refeyn secondary market activity?
Caplight tracks bids, offers, and trades in Refeyn's shares on secondary markets.